Shilpa Medicare

Stocks to Watch Today: TCS, Rail Vikas Nigam, Tata Power, HG Infra, Natco Pharma, Lupin, Shilpa Medicare, IDBI Bank in focus on 24 November

Stocks to Watch, 24 November: Stocks like Tata Consultancy Services, Rail Vikas Nigam, Tata Power Company, HG Infra Engineering, Kalpataru Projects International, Natco Pharma, Lupin, Shilpa Medicare, IDBI Bank, Kotak Mahindra Bank, Tata Chemicals, Samavardhana Motherson International, and RNIT AI Solutions will be in focus on November 24.

Shilpa Medicare shares surge 4 percent as key unit gets a VAI classification from US drug regulator

Shilpa Medicare's facility in Bengaluru is capable of manufacturing, packaging, testing, storage and distribution of two types of complex dosage forms - Oral Dissolving Films and Transdermal Systems.

Stocks to Watch Today: IndusInd Bank, Dabur India, Senco Gold, Rail Vikas Nigam, BEML, Shilpa Medicare, Godrej Consumer Products in focus on 7 July

Stocks to Watch, 7 July: Stocks like IndusInd Bank, Bank of India, Godrej Consumer Products, Dabur India, Senco Gold, Rail Vikas Nigam, Hazoor Multi Projects, BEML, Mahindra Lifespace Developers, Shilpa Medicare, and Tata Steel will be in focus on July 7.

Stocks to Watch Today: Bayer Cropscience, PG Electroplast, Aurobindo Pharma, IndiGo, Sagility India, Borana Weaves, Lumax Industries in focus on 27 May

Stocks to Watch, 27 May: Stocks like InterGlobe Aviation IndiGo, KEC International, PG Electroplast, India Pesticides, Sagility India, 360 ONE WAM, Aurobindo Pharma, Bayer Cropscience, Blue Dart Express, Shilpa Medicare, General Insurance Corporation of India, Maharashtra Seamless, Lumax Industries, Amber Enterprises India, KFin Technologies, Dabur India, and Borana Weaves will be in focus on May 27.

Stocks to Watch Today: Eicher Motors, Apollo Tyres, Lupin, Wendt India, HUL, Brigade, Genesys, Wipro, Shilpa Medicare, Yes Bank, Vascon Engineers in focus on 15 May

Stocks to Watch, 15 May: Stocks like Wendt India, Infosys, Hindustan Unilever, Brigade Enterprises, Genesys International Corporation, Wipro, Shilpa Medicare, Kirloskar Brothers, State Bank of India, Yes Bank, Gensol Engineering, Allcargo Logistics, Edelweiss Financial Services, Max Healthcare Institute, Navin Fluorine International, and Waaree Energies will be in focus on May 15.

Shilpa Medicare shares rise 3% on EIR from USFDA

Shilpa Medicare Share Price | The share touched a 52-week high of Rs 959.95 and a 52-week low of Rs 419.10 on 18 September, 2024 and 04 June, 2024, respectively.

Shilpa Medicare shares gain after arm gets EU GMP clearance for Dharwad plant

Shilpa Medicare Share Price | In the week ended May 2, the company share price declined by more than 7 percent, after reported gains in the previous three consecutive weeks.

Stocks to Watch Today: SBI, Kotak Mahindra Bank, Marico, Indian Bank, RR Kabel, AU SFB, Azad Engineering, IRCON, Concord Biotech in focus on 5 May

Stocks to Watch, 05 May: Stocks like Avenue Supermarts, Vardhman Textiles, Voltamp Transformers, PNB Gilts, Archean Chemical Industries, Sanofi Consumer Healthcare India, Gravita India, Sunteck Realty, City Union Bank, Aether Industries, Shilpa Medicare, BSE, GOCL Corporation, Tata Motors, Indraprastha Gas, and Tata Steel will be in focus on May 5.

Shilpa Medicare shares up 2% after arm partners with Swiss-based mAbTree Biologics for cancer drug

Shilpa Medicare share price: The therapy, a fully human monoclonal antibody, targets a newly identified immune checkpoint protein that could enhance T-cell activation and improve immune response against cancer.

Stocks to Watch Today: IndusInd Bank, HUL, Bank of Maharashtra, IRCON, Star Cement, Raymond Lifestyle, Shilpa Medicare, NBCC in focus on 18 March

Stocks to Watch, Mar 18: Stocks like Raymond Lifestyle, Aditya Birla Real Estate, Samvardhana Motherson International, NBCC (India), Coffee Day Enterprises, Triveni Engineering & Industries, Morepen Laboratories, Life Insurance Corporation of India, Suryoday Small Finance Bank, Religare Enterprises, and Gopal Snacks will be in focus on March 18.

Shilpa Medicare’s arm partners with Swiss-based mAbTree Biologics for novel cancer therapy

The therapy, a fully human monoclonal antibody, targets a newly identified immune checkpoint protein that could enhance T-cell activation and improve immune response against cancer.

Stocks to Watch on March 17: IndusInd Bank, Infosys, Brigade Enterprises and more

IndusInd Bank remains financially stable, with strong capital adequacy (16.46%) and liquidity ratios (LCR of 113%), as confirmed by the RBI. Infosys’ subsidiary, Infosys McCamish, reached a settlement agreement in the US for $17.5 million to resolve six class action lawsuits related to a cyber incident. Brigade Enterprises launched its new residential project, Brigade Eternia, in Yelahanka, Bengaluru, with an estimated revenue potential of ₹2,700 crore, along with a premium project in Devanahalli. Zydus Lifesciences successfully completed a USFDA inspection at its Ankleshwar facility with zero observations, affirming its adherence to regulatory standards. Shilpa Medicare’s subsidiary also passed a USFDA inspection at its Raichur facility with no observations, marking its second consecutive clean inspection.

Stocks to Watch Today: IndusInd Bank, Brigade, Maharashtra Seamless, GR Infraprojects, Shilpa Medicare, Alkem Labs, KEC International in focus on 17 March

Stocks to Watch on Mar 17: Stocks like Quality Power Electrical Equipments, Dr Reddy’s Laboratories, Tata Motors, Voltas, Tejas Networks, KPIT Technologies, Galaxy Surfactants, NTC Industries, 3M India, International Conveyors, Ksolves India, Zydus Lifesciences, and SpiceJet will be in focus on March 17.

Stocks to Watch Today: Lupin, Tata Power, Nazara Tech, Shilpa Medicare, GMR Airports, IRB Infra, Railtel, Shyam Metalics in focus on 10 March

Stocks to Watch, Mar 10: Stocks like India Pesticides, HFCL, NDR Auto Components, JSW Steel, GR Infraprojects, Biocon, Oil and Natural Gas Corporation, Container Corporation of India, Thangamayil Jewellery, Hinduja Global Solutions, IRB Infrastructure Developers, and AstraZeneca Pharma will be in focus on March 10.

Shilpa Medicare-Zydus JV gets USFDA nod for oral solution in cancer treatment

IMKELDI is a liquid formulation of cancer drug imatinib, and can help slow or prevent the growth of specific types of cancers and gastrointestinal tumors (GIST).

Shilpa Medicare shares rise 6% on CEP approvals from EDQM

The first CEP was, received on November 18, was for Octreotide, a synthetic peptide manufactured via solid-phase synthesis. The second CEP approval, received on November 19, was for Nifedipine, an active pharmaceutical ingredient (API) classified as a calcium-channel blocker.

Stock Radar: Medplus Health, PG Electroplast, Shilpa Medicare, Themis Medicare, Waaree Energies in focus on Tuesday

Stocks like Godavari Biorefineries, Gujarat Themis Biosyn, AstraZeneca Pharma, GVK Power and Infrastructure, GMR Airports Infrastructure, and Tilaknagar Industries will also be in focus on November 19.

Shilpa Medicare share jumps 8% as Q2 earnings impress

The revenue boost was attributed to robust growth in emerging markets alongside licensing success in the formulation and biologics segments, with the biologics business reporting a positive net profit for the first time.